IL152348A0 - Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid - Google Patents

Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid

Info

Publication number
IL152348A0
IL152348A0 IL15234801A IL15234801A IL152348A0 IL 152348 A0 IL152348 A0 IL 152348A0 IL 15234801 A IL15234801 A IL 15234801A IL 15234801 A IL15234801 A IL 15234801A IL 152348 A0 IL152348 A0 IL 152348A0
Authority
IL
Israel
Prior art keywords
alpha
beta
androst
dien
difluoro
Prior art date
Application number
IL15234801A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL152348A0 publication Critical patent/IL152348A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL15234801A 2000-07-21 2001-07-20 Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid IL152348A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017988.7A GB0017988D0 (en) 2000-07-21 2000-07-21 Novel process
PCT/GB2001/003289 WO2002008243A1 (en) 2000-07-21 2001-07-20 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid

Publications (1)

Publication Number Publication Date
IL152348A0 true IL152348A0 (en) 2003-05-29

Family

ID=9896132

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15234801A IL152348A0 (en) 2000-07-21 2001-07-20 Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
IL152348A IL152348A (en) 2000-07-21 2002-10-17 Oxidation process for the preparation of the intermediate 6 alpha, 9 alpha - difluoro 11 - beta - 17 alpha - dehydroxy 16 - alpha - methyl (androst) - 1,4 – diane - 3 - on 17 - beta - carboxylic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152348A IL152348A (en) 2000-07-21 2002-10-17 Oxidation process for the preparation of the intermediate 6 alpha, 9 alpha - difluoro 11 - beta - 17 alpha - dehydroxy 16 - alpha - methyl (androst) - 1,4 – diane - 3 - on 17 - beta - carboxylic acid

Country Status (26)

Country Link
US (1) US20040043974A1 (enExample)
EP (1) EP1301526B1 (enExample)
JP (1) JP2004504403A (enExample)
KR (1) KR100787293B1 (enExample)
CN (1) CN1315864C (enExample)
AT (1) ATE398628T1 (enExample)
AU (2) AU2001270906B2 (enExample)
BR (1) BR0110430A (enExample)
CA (1) CA2406963A1 (enExample)
CY (1) CY1108553T1 (enExample)
CZ (1) CZ302592B6 (enExample)
DE (1) DE60134472D1 (enExample)
DK (1) DK1301526T3 (enExample)
ES (1) ES2307628T3 (enExample)
GB (1) GB0017988D0 (enExample)
HK (1) HK1056179B (enExample)
HU (1) HUP0301108A3 (enExample)
IL (2) IL152348A0 (enExample)
MX (1) MXPA02010967A (enExample)
NO (1) NO324836B1 (enExample)
NZ (1) NZ522083A (enExample)
PL (1) PL206652B1 (enExample)
PT (1) PT1301526E (enExample)
SI (1) SI1301526T1 (enExample)
WO (1) WO2002008243A1 (enExample)
ZA (1) ZA200208372B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
CO5310534A1 (es) 2000-08-05 2003-08-29 Glaxo Group Ltd Nuevos derivados de androstano anti-inflamatorios
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
ES2314052T3 (es) 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
JP2006522028A (ja) * 2003-04-04 2006-09-28 アルファーマ エーピーエス ステロイド性カルボチオ酸誘導体の製造方法および中間体
EP1466920A1 (en) * 2003-04-04 2004-10-13 Alpharma APS Process for the preparation of steroidal 17 beta-carbothioates
EP1526139A1 (en) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters
GB0612027D0 (en) 2006-06-16 2006-07-26 Glaxo Group Ltd Novel process
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
WO2012029077A2 (en) 2010-09-01 2012-03-08 Cadila Healthcare Limited Process for preparing fluticasone propionate/furoate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
US4198336A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. Chemical process for preparing androsta-4-ene 17α-carboxylic acids
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
GB2088877B (en) * 1980-02-15 1984-07-04 Glaxo Group Ltd Androstane 17 carbothioates
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
US6197761B1 (en) * 1995-12-29 2001-03-06 Glaxo Wellcome Inc. 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
MXPA02009814A (es) * 2000-04-04 2003-03-27 Celanese Int Corp Composiciones de revestimiento receptivas de tinta que contienen alcohol polivinilico injertado con grupos funcionales amina.
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions

Also Published As

Publication number Publication date
CN1437610A (zh) 2003-08-20
ATE398628T1 (de) 2008-07-15
ES2307628T3 (es) 2008-12-01
CA2406963A1 (en) 2002-01-31
PT1301526E (pt) 2008-09-09
IL152348A (en) 2008-08-07
NO324836B1 (no) 2007-12-17
US20040043974A1 (en) 2004-03-04
EP1301526B1 (en) 2008-06-18
HUP0301108A3 (en) 2008-04-28
PL359462A1 (en) 2004-08-23
PL206652B1 (pl) 2010-09-30
NZ522083A (en) 2004-06-25
NO20025054D0 (no) 2002-10-21
GB0017988D0 (en) 2000-09-13
KR100787293B1 (ko) 2007-12-20
NO20025054L (no) 2002-11-05
HK1056179A1 (en) 2004-02-06
AU2001270906B2 (en) 2005-10-13
MXPA02010967A (es) 2003-03-27
ZA200208372B (en) 2004-02-11
HUP0301108A2 (hu) 2003-08-28
JP2004504403A (ja) 2004-02-12
CN1315864C (zh) 2007-05-16
DE60134472D1 (de) 2008-07-31
DK1301526T3 (da) 2008-10-06
AU7090601A (en) 2002-02-05
CZ20023472A3 (cs) 2003-04-16
BR0110430A (pt) 2003-07-08
WO2002008243A1 (en) 2002-01-31
EP1301526A1 (en) 2003-04-16
SI1301526T1 (sl) 2008-10-31
CY1108553T1 (el) 2014-04-09
HK1056179B (en) 2009-07-17
KR20030028736A (ko) 2003-04-10
CZ302592B6 (cs) 2011-07-27

Similar Documents

Publication Publication Date Title
IL152348A0 (en) Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
ZA200410000B (en) Method for producing C13-alcohol mixtures
MXPA04000634A (es) Barra de detergente mejorada y un proceso para fabricacion.
PL367298A1 (en) Process for the production of beraprost and its salts
MX9601105A (es) Proceso para la preparacion de etil-n-(2,3-dicloro-6-nitrobencil)glicina.
GB9409705D0 (en) Novel compounds
PL368722A1 (en) Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
AU8182701A (en) Method for producing 5-aminosalicyclic acid
ZA200005110B (en) Process for preparing intermediates.
HU0004701D0 (enExample)
IL149526A0 (en) Process for the preparation of ketimines
GEP20033119B (en) Novel Octahydro-6, 10-Dioxo-6H-Pyridazino {1,2-a}{1 Carboxylic Acid Derivatives, Method for Preparation and Use Thereof
IL147728A0 (en) Method for making debromohymenialdisine and analogs thereof
EG20562A (en) Process for preparing glutaramide derivatives
HU0102118D0 (en) Process for chloromethylation
PL363756A1 (en) Process for preparing fluconazole and its crystal modifications
MY127737A (en) Novel process for the preparation of pyrazolopyrimidinones
MY126799A (en) Process and intermediates for making 4-cyanosubstituted cyclohexanoic acids.
AU6684500A (en) Novel c-19-halogen-substituted steroids of the androst-9(11)-ene-series, methodsfor the production and use thereof
IL145017A (en) METHOD FOR PRODUCING 4,4-DIMETHYL-3beta-HYDROXYPREGNA-8,14-DIENE-21 -CARBOXILIC ACID ESTERS AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD
HU0001287D0 (en) New intermediate and process for its production
WO2003029267A3 (es) PROCEDIMIENTO PARA LA OBTENCION DE 17β-(SUSTITUIDO)-3-OXO-Δ1,2-4-AZAESTEROIDES E INTERMEDIOS
TW368496B (en) A process for the preparation of 2-aryl-propionic and 2-aryl-acetic acids starting from aryl-olefins
MX9605632A (es) Procedimiento para la preparacion de derivados azabiciclicos.
MXPA03000917A (es) Procedimiento para la preparacion de 9,10-dihidropirrolo (2,1-b)(1,3)benzotiazepinas sustituidas con 9-amino.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed